文献速递类风湿关节炎

瓜氨酸化聚集蛋白聚糖表位是类风湿关节炎患者自反应性CD4+ T细胞的靶点

Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD4+ T Cells in Patients With Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2019-03-08

该研究通过预测瓜氨酸化聚集蛋白聚糖肽段与HLA-DRB1*04:01的结合,并利用HLA四聚体染色和单细胞克隆,在类风湿关节炎(RA)患者外周血中直接可视化并表征了聚集蛋白聚糖特异性T细胞。研究发现RA患者中瓜氨酸化聚集蛋白聚糖特异性T细胞频率显著高于健康对照,且与针对同一抗原的抗体水平显著相关。结果表明这些T细胞和抗体可能是监测RA患者或高危人群的潜在标志物。

要点

  • RA患者外周血中瓜氨酸化聚集蛋白聚糖特异性T细胞频率显著高于健康对照。
  • 瓜氨酸化聚集蛋白聚糖特异性T细胞频率与抗瓜氨酸化聚集蛋白聚糖抗体水平显著相关。
  • 瓜氨酸化聚集蛋白聚糖特异性T细胞和抗体可能是监测RA患者或高危人群的潜在标志物。

核心结论

  • 类风湿关节炎患者中存在识别瓜氨酸化聚集蛋白聚糖的T细胞,且其频率与针对同一抗原的抗体相关。
  • 聚集蛋白聚糖特异性T细胞和抗体可能是监测RA患者或高危人群的潜在标志物。

研究设计与样本

  • 研究使用先前发表的扫描算法预测具有DRB1*04:01结合基序的瓜氨酸化聚集蛋白聚糖肽段。
  • 对可检测结合的肽段通过HLA四聚体染色评估免疫原性,随后进行单细胞克隆。
  • 通过四聚体染色和增殖实验评估对瓜氨酸化肽段的选择性。
  • 进行离体四聚体染色评估外周血中聚集蛋白聚糖特异性T细胞的频率。
  • 通过比较RA患者和对照的T细胞频率,并将聚集蛋白聚糖特异性T细胞与聚集蛋白聚糖特异性抗体水平相关,评估疾病关联。

主要发现

  • 鉴定出6个免疫原性肽段,其中2个是外周血中主要的T细胞靶点。
  • 这2个表位在HLA结合残基处瓜氨酸化,并具有同源序列。
  • RA患者中瓜氨酸化聚集蛋白聚糖特异性T细胞频率显著高于健康受试者。
  • T细胞频率与针对瓜氨酸化聚集蛋白聚糖的抗体显著相关。

关键数值与推荐

  • 瓜氨酸化聚集蛋白聚糖肽段预测基于DRB1*04:01结合基序。
  • 鉴定出6个免疫原性肽段,其中2个为外周血主要T细胞靶点。
  • RA患者瓜氨酸化聚集蛋白聚糖特异性T细胞频率显著高于健康受试者。
  • T细胞频率与抗瓜氨酸化聚集蛋白聚糖抗体显著相关。

临床怎么用

  • 瓜氨酸化聚集蛋白聚糖特异性T细胞和抗体可作为监测RA患者或高危人群的潜在标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recognition of citrullinated antigens such as vimentin, fibrinogen, and α-enolase is associated with rheumatoid arthritis (RA). Emerging data suggest that the matrix protein aggrecan is also recognized as a citrullinated antigen. This study was undertaken to directly visualize Cit-aggrecan-specific T cells and characterize them in patients with RA. METHODS: Citrullinated aggrecan peptides with likely DRB1*04:01 binding motifs were predicted using a previously published scanning algorithm. Peptides with detectable binding were assessed for immunogenicity by HLA tetramer staining, followed by single cell cloning. Selectivity for citrullinated peptide was assessed by tetramer staining and proliferation assays. Ex vivo tetramer staining was then performed to assess frequencies of aggrecan-specific T cells in peripheral blood. Finally, disease association was assessed by comparing T cell frequencies in RA patients and controls and correlating aggrecan-specific T cells with levels of aggrecan-specific antibodies. RESULTS: We identified 6 immunogenic peptides, 2 of which were the predominant T cell targets in peripheral blood. These 2 epitopes were citrullinated at HLA binding residues and shared homologous sequences. RA patients had significantly higher frequencies of Cit-aggrecan-specific T cells than healthy subjects. Furthermore, T cell frequencies were significantly correlated with antibodies against citrullinated aggrecan. CONCLUSION: Our findings indicate that T cells that recognize citrullinated aggrecan are present in patients with RA and correlate with antibodies that target this same antigen. Consequently, aggrecan-specific T cells and antibodies are potentially relevant markers that could be used to monitor patients with RA or at-risk subjects.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Rims C, Uchtenhagen H, Kaplan MJ, et al. Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD4+ T Cells in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2019. PMID: 30390384. doi:10.1002/art.40768

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。